These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18557724)

  • 1. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys.
    Smith RN; Kawai T; Boskovic S; Nadazdin O; Sachs DH; Cosimi AB; Colvin RB
    Am J Transplant; 2008 Aug; 8(8):1662-72. PubMed ID: 18557724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates.
    Smith RN; Kawai T; Boskovic S; Nadazdin O; Sachs DH; Cosimi AB; Colvin RB
    Am J Transplant; 2006 Aug; 6(8):1790-8. PubMed ID: 16780551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.
    Everly MJ; Everly JJ; Arend LJ; Brailey P; Susskind B; Govil A; Rike A; Roy-Chaudhury P; Mogilishetty G; Alloway RR; Tevar A; Woodle ES
    Am J Transplant; 2009 May; 9(5):1063-71. PubMed ID: 19344434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of chronic antibody-mediated rejection in the making.
    Bravou V; Galliford J; McLean A; Willicombe M; Taube D; Cook HT; Roufosse C
    Clin Nephrol; 2013 Oct; 80(4):306-9. PubMed ID: 22579273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
    Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection.
    Abe M; Sawada T; Horita S; Toma H; Yamaguchi Y; Teraoka S
    Clin Transplant; 2003; 17 Suppl 10():14-9. PubMed ID: 12823251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
    Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
    Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
    Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
    Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.
    Wiebe C; Gareau AJ; Pochinco D; Gibson IW; Ho J; Birk PE; Blydt-Hansen T; Karpinski M; Goldberg A; Storsley L; Rush DN; Nickerson PW
    Am J Transplant; 2017 Mar; 17(3):703-711. PubMed ID: 27539748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
    Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S
    Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
    Haas M; Sis B; Racusen LC; Solez K; Glotz D; Colvin RB; Castro MC; David DS; David-Neto E; Bagnasco SM; Cendales LC; Cornell LD; Demetris AJ; Drachenberg CB; Farver CF; Farris AB; Gibson IW; Kraus E; Liapis H; Loupy A; Nickeleit V; Randhawa P; Rodriguez ER; Rush D; Smith RN; Tan CD; Wallace WD; Mengel M;
    Am J Transplant; 2014 Feb; 14(2):272-83. PubMed ID: 24472190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.